54,986 Shares in Cameco Corporation $CCJ Purchased by D.A. Davidson & CO.

D.A. Davidson & CO. purchased a new stake in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 54,986 shares of the basic materials company’s stock, valued at approximately $4,766,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Bank of America Corp DE acquired a new stake in Cameco during the second quarter valued at $735,498,000. Canada Pension Plan Investment Board acquired a new position in Cameco in the 2nd quarter worth about $420,346,000. BlackRock Inc. acquired a new position in Cameco in the 2nd quarter worth about $381,091,000. Cibc World Market Inc. acquired a new position in Cameco in the 2nd quarter worth about $354,022,000. Finally, Amundi raised its stake in shares of Cameco by 13.7% during the 2nd quarter. Amundi now owns 2,992,074 shares of the basic materials company’s stock worth $304,773,000 after purchasing an additional 359,375 shares in the last quarter. 70.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Jefferies Financial Group initiated coverage on shares of Cameco in a research note on Thursday, September 3rd. They issued a “buy” rating and a $138.00 target price for the company. Barclays dropped their price target on shares of Cameco from $97.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Citigroup restated a “positive” rating on shares of Cameco in a report on Wednesday, July 15th. Bank of America reduced their price objective on shares of Cameco from $143.00 to $140.00 and set a “buy” rating for the company in a research note on Thursday, July 9th. Finally, Weiss Ratings upgraded shares of Cameco from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Twelve research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $147.93.

More Cameco News

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: Uranium prices rose approximately 8% during the quarter, while Cameco said nuclear-industry fundamentals remain strong. The company reiterated that its disciplined strategy and integrated exposure, including Westinghouse, support long-term value creation. Cameco Q3 2026 earnings call transcript
• Positive Sentiment: Cameco declared an annual dividend, with the company signaling a payment of approximately $0.24, providing continued shareholder income despite near-term earnings volatility. Cameco dividend and production outlook
• Neutral Sentiment: The company narrowed its 2026 uranium production outlook to 19.5 million–20.5 million pounds. The tighter range improves visibility, but the lower production pace highlights ongoing execution and maintenance risks. Cameco production outlook
• Negative Sentiment: Third-quarter adjusted earnings per share were $0.10, below the $0.23 analyst consensus. Profit for the first nine months also declined, reinforcing concerns about earnings volatility. Cameco stock falls after lower nine-month profit
• Negative Sentiment: Planned maintenance and an outage at Key Lake reduced production by about 20% and sharply pressured quarterly revenue and earnings. Investors are concerned that mine disruptions, rising costs, and Westinghouse execution could undermine Cameco’s raised revenue outlook. Cameco Q3 2026 earnings
• Negative Sentiment: Unusually heavy put-option activity—49,822 contracts, more than double typical volume—signals increased near-term hedging or bearish speculation, although it does not by itself confirm future performance.

Cameco Trading Down 7.9%

NYSE:CCJ opened at $76.87 on Friday. The company’s 50 day moving average is $90.63 and its 200-day moving average is $104.19. The company has a quick ratio of 2.10, a current ratio of 3.06 and a debt-to-equity ratio of 0.14. Cameco Corporation has a 12 month low of $73.89 and a 12 month high of $135.24. The firm has a market cap of $33.48 billion, a price-to-earnings ratio of 116.47, a P/E/G ratio of 1.55 and a beta of 1.17.

Cameco (NYSE:CCJ) (TSE:CCO) last released its earnings results on Friday, July 31st. The basic materials company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.13). Cameco had a return on equity of 7.59% and a net margin of 10.20%. The firm had revenue of $573.06 million for the quarter, compared to analyst estimates of $579.60 million. During the same period in the prior year, the firm earned $0.71 EPS. The firm’s revenue was down 6.8% on a year-over-year basis. Equities analysts anticipate that Cameco Corporation will post 1.08 EPS for the current year.

Cameco Profile

Cameco Corporation is a Canadian uranium company that explores for, mines, processes and supplies uranium used to generate nuclear power. The company produces uranium concentrates, commonly known as yellowcake, which are sold to nuclear utilities and other customers for conversion into nuclear fuel.

Cameco’s principal mining operations are located in northern Saskatchewan, including the McArthur River and Cigar Lake mines. It also operates the Key Lake uranium mill and has interests in uranium assets in Kazakhstan through the Inkai joint venture.